本文へ移動
cccskills
無料GitHub で公開

market-share-tracking

Weekly product-level commercial tracking — TRx/NRx with current/4-wk/12-wk share and YoY, launch curves overlaid with same-class analogs plus a consensus-implied trajectory, LOE/biosimilar erosion series, GTN/net-price stress brackets, and per-row data-caveat discipline. Use to track any launched drug, biologic, device, or vaccine against its class and consensus.

インストール方法を見る

含まれるファイル(3)

  • SKILL.md7.5 KB
  • references/knowledge-frameworks.md4.8 KB
  • references/modes.md1.2 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Methodology inspired by publicly taught commercial-tracking approaches; all text is an original paraphrase.

Defaults

ParameterDefault ValueRationale
windowscurrent / 4-wk / 12-wkThree-window share + growth lattice
growth_metricTRx YoYWeekly, 4-wk, and 12-wk YoY alongside share
analog_count2≥2 named same-class analogs on the launch board
consensus_sourcecompany-levelProduct consensus via segment-share math [DEDUCTED]
caveatsper-rowA number without a caveat annotation is a defect

Preflight

Run canonical pre-flight per contracts/preflight.md. Include the X-Agentii-Trace header on every tool call per contracts/x-agentii-trace-header.md — carry the _run_id from your first tool result and name yourself (and your parent, if you were spawned). Confirm ticker resolution via search_companies before commercial-track queries.

Triggers

  • "Is [product] tracking above or below consensus?"
  • "How is the [product] launch trending?"
  • "Build the launch board for [product] with class analogs."
  • "What is the consensus-implied trajectory for [product]?"
  • "Show [product]'s TRx share and YoY for the last 12 weeks."
  • "How fast is [biosimilar] eroding [branded product]?"
  • "Stress-test [product]'s net price and GTN."
  • "What are the caveats on [product]'s scripts?"
  • "Track installed base and utilization for [device]."
  • "How is ACIP-cohort uptake tracking for [vaccine]?"

Production Grounding

  • Three-window lattice: current / 4-wk / 12-wk share and YoY; previous values shown next to new values.
  • Launch boards: actuals vs ≥2 named same-class analogs + consensus-implied trajectory (consensus sales ÷ net price ÷ script duration → required TRx → linear path); assumptions stated.
  • LOE erosion: entrant share vs branded YoY decay with approval/launch dates.
  • GTN/net-price stress: GTN brackets (50→80% flex), $/Rx = quarterly sales ÷ scripts, channel mix; half-of-sales-minus-volume net price is a stated judgment [VIEW].
  • Modality vocabularies: scripts/share/erosion (drugs & biologics); installed base, placements/procedures, utilization, ASP (devices); doses/serials, procurement, ACIP-cohort uptake (vaccines); never a script number for a device or vaccine.
  • Per-row caveats: restricted scripts, rounding, indication-mixed, IV invisibility, holiday weeks — every row carries its caveat or coverage_gap.
  • Badges: [FACT]/[DEDUCTED]/[VIEW] with the summary table.

Data Source Priority

  1. search_commercial_track — weekly track rows with stored previous values.
  2. Company-reported product sales: 10-K/Q XBRL (get_statement) and MD&A (search_documents).
  3. Transcript commentary on scripts/share/persistence via search_documents.
  4. Payer coverage/PA announcements and openFDA label events via search_documents + list_sources.
  5. Consensus: search_earnings_calendar company-level only; licensed Rx panels never assumed.

Methodology

Retrieval Scope

unstructured_document_search

Retrieval Strategy

  1. Resolve basket tickers via search_companies; map products to companies.
  2. Pull weekly rows via search_commercial_track (previous values stored alongside).
  3. Compute the three-window lattice from stored history; attach per-row caveats.
  4. Build the launch board: ≥2 named analog curves + consensus-implied trajectory arithmetic.
  5. LOE events: pair entrant share with branded YoY decay; date approval/launch.
  6. Stress net price (GTN brackets, $/Rx, channel mix); label derived values [DEDUCTED].
  7. Ground in knowledge (sectors=med); cite /v/ records.

Temporal Scope

See frontmatter temporal_scope block. Rolling windows recompute from stored history; holiday weeks are labeled.

Tool Allowlist

See frontmatter allowed_tools.

Protocol

  1. Ticker + product resolution
  2. Commercial-track pull (stored history)
  3. Three-window lattice computation
  4. Launch-board overlay + implied trajectory
  5. LOE erosion series (when applicable)
  6. GTN/net-price stress + caveat audit

Modes

  • Drug / biologic (default): scripts/share/erosion; LOE/biosimilar series.
  • Device: installed base, placements/procedures, utilization, ASP; no script numbers.
  • Vaccine: doses/serials, procurement, ACIP-cohort uptake; approval ≠ commercial availability.
  • Basket: multi-ticker watchlist with per-name sections.

Tool Fallbacks

FailureFallback
search_commercial_track emptyCompany-reported sales (get_statement/search_documents); annotate coverage_gap
Scripts restricted (IQVIA)State the restriction verbatim; refuse a share number; use company-reported metrics
No product consensusSegment share × company consensus [DEDUCTED]; else coverage_gap with required inputs
No analog seriesNamed-analog list with disclosed sales/scripts; flag degraded
One-quarter issuer / pre-revenuePipeline/cash-runway logic; no share arithmetic

Output File

{ticker}/{YYYY-MM-DD_HHMM}_market-share-tracking_{affix}.md (basket: watchlist/{YYYY-MM-DD_HHMM}_market-share-tracker_{affix}.md)

Output Structure

  1. Executive Summary — actuals vs consensus-implied trajectory, 2-3 sentences
  2. Launch Board — actuals vs ≥2 named analogs + consensus-implied path with stated arithmetic
  3. Share & YoY Lattice — current/4-wk/12-wk share and YoY with previous values
  4. LOE / Erosion Series — entrant share vs branded YoY decay with approval/launch dates
  5. Net-Price & GTN Stress — $/Rx, GTN brackets, channel mix, [DEDUCTED] labels
  6. Caveat Register — per-row annotations + coverage_gap list
  7. Coverage Gaps — missing sources and degraded modes

Error Handling

ErrorFallback
No commercial-track rowsCompany-reported sales only; annotate coverage_gap — never fabricate scripts
Product not in med universeResolve via product/company match; surface the classification gap
Consensus absentcoverage_gap with required inputs (sales, net price, script duration)

Memory Load

See contracts/memory-load.md.

Snapshot

See contracts/snapshot-synthesis.md.

Final Summary (TUI)

Include ### Key Citations block with 0-10 clickable /v/ URLs.

References

  • contracts/citation-and-memory.md
  • contracts/output-frontmatter-schema.md
  • contracts/memory-load.md
  • contracts/snapshot-synthesis.md
  • contracts/preflight.md
  • references/knowledge-frameworks.md

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

3-statement financial model, integrated IS BS CF, income statement projection, balance sheet forecast, cash flow statement, cross-statement balancing, financial model build, operating model, three statement model, integrated financial statements

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

Institutional-grade equity research skills for AI agents. 80 Claude-type skills across 14 verticals (equity-research-core, models-and-pitches, bio-pharm, scenarios, quantitative-analysis, idea-generation, options-derivatives, business-intelligence, industry-analysis, macro-strategy, portfolio-strategy, technical-analysis, risk-and-psychology, trading-as-business) powered by agentii.ai's agent-use-ready SEC filing data plane — SEC filings and 15K+ earnings call transcripts, 15.99M XBRL facts, and company profiles for 1,146+ US-public-equity tickers. Features the three-layer retrieval protocol (Document Discovery → Page Map → Deep Read, with deep-outline escalation) — measured, not asserted: 97.5% saved against a sequential read, and the page map itself is 10.0% of one (spec 062 T030, 2026-09-23) — server-side parallel multi-period search via search_cross_period, a full Excel/PPT generation pipeline with 3-tier office backend support, and the spec-046 governance layer (constitution, thesis and single-skill modes, mechanical gates, and a template-owned disclaimer on generated reports).

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

audit-xls

無料

Audit spreadsheet, formula error detection, hardcoded cell finder, cross-sheet reference audit, workbook auditor, Excel model audit, financial model QA, spreadsheet review, cell dependency trace, formula integrity check

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

Business model classification, business model analysis, structural analysis of how a company makes money, product offering decomposition, distribution channel analysis, customer segment analysis, revenue model identification, market sizing TAM SAM SOM, competitive positioning, business unit performance, management team & leadership analysis, what does the company sell, how does the company go to market, business model type platform service product, channel mix direct vs indirect, revenue concentration risk, CEO CFO executive backgrounds and changes

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

challenge

無料

Adversarial verification of research theses — cross-run/cross-thesis contradiction via the entity index, pre-mortem (Klarman/Kahneman: assume the loss already happened, reverse the path), inversion (Munger: invert, always invert), and wrong_if falsifiability review. ≈50-finding cap sorted by severity; content-derived finding IDs; incremental scoping with three backstops; lifecycle hooks at pillar-complete / thesis-complete / pre-reduction.

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

Chart pattern recognition, price action patterns, candlestick signal bars, pullback bar counting H1/H2/H3/H4, trend channels, micro channels, trading ranges, breakouts, major trend reversals 5-step sequence, wedges, double tops and bottoms, triangles, head and shoulders, climaxes, measured moves, support and resistance

日本語の概要は準備中です。原文の説明を表示しています。

agentii-ai/agentii-investment-intelligence2072026年9月29日 更新

agentii-ai のスキルをすべて見る

このスキルの問題を報告する